Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FXT3E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $12,467 delivery order to Amerisourcebergen Drug Corp on April 15, 2026, for SKYRIZI 150 mg/ml pen medication, with an ultimate completion date of April 16, 2026.
The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no set-aside.
Quick answers
Who was awarded contract SPE2DR26FXT3E?
SPE2DR26FXT3E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 15, 2026.
How much is contract SPE2DR26FXT3E worth?
The government has obligated $12,467 on SPE2DR26FXT3E.
Is contract SPE2DR26FXT3E an order under another contract?
Yes. SPE2DR26FXT3E is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXT3E competed?
The extent of competition for SPE2DR26FXT3E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award